Agenus Provides Update on Balstilimab Development

Go back to Agenus Provides Update on Balstilimab Development
AGENUS (NASDAQ: AGEN) Delayed: 3.00 +0.04 (1.35%)
Previous Close $2.96    52 Week High $7.49 
Open $3.00    52 Week Low $2.61 
Day High $3.10    P/E N/A 
Day Low $2.91    EPS $-1.10 
Volume 868,396